Why Ovarian Cancer Spreads Rapidly Before Detection

Ovarian cancer is the deadliest gynecological cancer, largely because We see typically discovered only after it has spread widely throughout the abdomen. A study led by Nagoya University, published in Science Advances on February 9, 2026, has identified the biological mechanism that allows this cancer to advance so rapidly.

The research reveals that cancer cells do not operate in isolation. Instead, they recruit assistance from mesothelial cells, which are normally protective cells that line the abdominal cavity. By forming a secret cell alliance, these two cell types work together to invade new tissues more effectively than cancer cells could on their own.

The Mechanism of Hybrid Cell Clusters

To understand the spread of the disease, researchers analyzed abdominal fluid from patients with ovarian cancer. They discovered that cancer cells rarely drift freely as individuals. Instead, they often attach themselves to mesothelial cells to form hybrid spheres.

The study found that approximately 60% of all cancer spheres in the abdominal fluid contain these recruited mesothelial cells. This partnership is facilitated by a protein released by the cancer cells known as TGF-β1.

The TGF-β1 protein transforms the mesothelial cells, causing them to develop spike-like structures called invadopodia. These structures act as tools that do the digging for cancer, cutting through tissue and creating pathways. The cancer cells then follow these established paths to invade new areas of the abdomen.

Comparison with Other Cancer Metastasis

The way ovarian cancer spreads differs fundamentally from the metastasis seen in other common cancers, such as breast or lung cancer. In those cases, cancer cells typically enter blood vessels and travel through the bloodstream to reach distant organs.

Because blood moves in predictable paths through vessels, doctors can sometimes track these cancers using blood tests. Ovarian cancer cells, however, avoid blood vessels entirely during their initial spread.

When ovarian cancer develops, cells break off from the primary tumor and enter the abdominal fluid. In this floating stage, the cells are carried to different spots in the abdomen by the movement of the fluid, which is influenced by the patient’s breathing and body movements.

Because the abdominal fluid has no fixed path, the spread is less predictable and often occurs before doctors can detect the disease through standard means.

Impact on Treatment and Diagnosis

The discovery of these hybrid cell clusters explains not only the speed of the cancer’s spread but also its resilience to treatment. The research indicates that these hybrid spheres are more resistant to chemotherapy than cancer cells acting alone.

This resistance contributes to the high mortality rate associated with the disease, as the cancer is often advanced by the time a diagnosis is made and the hybrid clusters may shield the cancer cells from the full effect of chemotherapy.

By uncovering this specific interaction between cancer cells and mesothelial cells, the Nagoya University researchers have identified a critical weakness. This finding suggests that future treatments may be able to target the recruitment of mesothelial cells or the production of TGF-β1 to stop the invasion process before the cancer spreads throughout the abdominal cavity.